)
Vimta Labs (524394) investor relations material
Vimta Labs Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 FY26 total income was ₹1,005 million, up 10.2% year-over-year, driven by pharmaceutical and food testing services.
Nine months FY26 total income reached ₹3,043 million, up 20.7% year-over-year.
EBITDA margins remained robust at 34.3% for Q3 and 35.1% for 9M, with PAT margins at 17.5% and 18.5% respectively.
EPS stood at ₹3.96 for Q3 and ₹12.67 for 9M FY26.
Unaudited financial results for the quarter and nine months ended December 31, 2025, were reviewed and approved by the Audit Committee and Board on January 28, 2026.
Financial highlights
Q3 FY26 EBITDA was ₹344 million, PBT ₹234 million, and PAT ₹176 million, all including exceptional items.
Nine months FY26 EBITDA reached ₹1,068 million, PBT ₹749 million, and PAT ₹564 million.
Cash and cash equivalents at the end of 9M FY26 were ₹666.6 million.
Q3 FY26 saw a CAPEX cash outflow of ₹248.3 million.
Bonus shares issued in June 2025 in a 1:1 ratio, with prior period EPS restated accordingly.
Outlook and guidance
Management remains confident in near- and long-term growth, citing favorable market conditions and capacity expansions.
Q4 is expected to be stronger, following historical trends and seasonal benefits in food testing.
The INR 500 crore annual revenue target may not be fully achieved this year, but management expects a satisfactory outcome.
Biologics contract research and development services to be commercialized in Q1 next fiscal, with initial focus on client acquisition.
The company will continue to monitor the impact of the new labour code and provide updates as needed.
- TimeTickerHeadlineOpen
- LTRX
Q2 revenue $29.8M, non-GAAP EPS $0.04, drone revenue guidance raised, cash at $23M. - AFL
Net earnings dropped, but adjusted EPS and U.S. sales grew; $800M in share repurchases. - CFLT
Stockholders will vote on the IBM merger amid litigation and enhanced disclosures. - GEOS
Revenue fell 31% and a net loss of $9.8 million was reported amid broad market headwinds. - SNT
Positive Phase 2 amsulostat data and strong funding position drive near-term value. - OFX
Strategic review launched as non-FX revenue surges but NOI and client activity decline. - RSI
Record financial results, all motions passed, and LEAP Project advances for future growth. - CNXN
Record gross profit and margin gains, with cost savings and AI focus driving 2026 growth. - ARAY
Q2 FY26 revenue down 12%, net loss $13.8M, FY26 guidance cut, transformation plan underway. - PLUS
Double-digit growth, raised guidance, and a $0.25 dividend marked a strong quarter.
Next Vimta Labs earnings date
Next Vimta Labs earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)